tyrosine has been researched along with Carcinoma, Transitional Cell in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Albarrán, V; Alía, V; Barrill, AM; Calvo, JC; Chamorro, J; Gajate, P; Guerrero, P; Orejana, I; Pérez de Aguado, P; Pozas, J; Rosero, DI; San Román, M; Sotoca, P | 1 |
| Burgess, EF; Clark, PE; Grigg, CM; Livasy, CA; Matulay, JT; Raghavan, D; Symanowski, JT | 1 |
| Akçay, T; Ataus, S; Cakatay, U; Telci, A; Yalçin, V; Yilmaz, IA | 1 |
1 review(s) available for tyrosine and Carcinoma, Transitional Cell
| Article | Year |
|---|---|
Her-2 Targeted Therapy in Advanced Urothelial Cancer: From Monoclonal Antibodies to Antibody-Drug Conjugates.
Topics: Antibodies, Monoclonal; Antineoplastic Agents, Immunological; Carcinoma, Transitional Cell; Humans; Immunoconjugates; Tyrosine; Urinary Bladder Neoplasms | 2022 |
2 other study(ies) available for tyrosine and Carcinoma, Transitional Cell
| Article | Year |
|---|---|
Low co-expression of PD-L1 and oncogenic receptor tyrosine kinases HER2 and cMET in urothelial carcinoma is associated with discordant expression between primary and metastatic sites.
Topics: B7-H1 Antigen; Biomarkers, Tumor; Carcinoma, Transitional Cell; Humans; Immunohistochemistry; Tyrosine; Urinary Bladder Neoplasms | 2023 |
Relation between bladder cancer and protein oxidation.
Topics: Aged; Analysis of Variance; Biomarkers, Tumor; Blood Proteins; Carcinoma, Transitional Cell; Case-Control Studies; Humans; Iron; Lipid Peroxidation; Male; Middle Aged; Neoplasm Staging; Oxidation-Reduction; Oxidative Stress; Probability; Prognosis; Reference Values; Risk Assessment; Sensitivity and Specificity; Sulfhydryl Compounds; Tyrosine; Urinary Bladder Neoplasms | 2003 |